The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Efficacy and safety of regorafenib in Korean patients with advanced gastrointestinal stromal tumor after failure of imatinib and sunitinib: A multicenter study based on the management access program.

Myoung Kyun  Son

No Relationships to Disclose

Min-Hee  Ryu

No Relationships to Disclose

Joon Oh  Park

Research Funding - GlaxoSmithKline; Sanofi

Seock-Ah  Im

No Relationships to Disclose

Baek-Yeol  Ryoo

No Relationships to Disclose

Sook Ryun  Park

No Relationships to Disclose

Yoon-Koo  Kang

Honoraria - Bayer; Novartis

Consulting or Advisory Role - Bayer; Novartis

Research Funding - Bayer; Novartis